Research Topics
Genomes and Genes
| P M RidkerSummaryAffiliation: Harvard University Country: USA Publications
| Collaborators
|
Detail Information
Publications
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in womenP M Ridker
Center for Cardiovascular Disease Prevention, and Division of Cardiology, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
N Engl J Med 342:836-43. 2000..Since inflammation is believed to have a role in the pathogenesis of cardiovascular events, measurement of markers of inflammation has been proposed as a method to improve the prediction of the risk of these events...
Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) InvestigatorsP M Ridker
Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, The Children s Hospital Medical Center, Boston, MA, USA
Circulation 100:230-5. 1999..We evaluated whether long-term therapy with pravastatin, an agent that reduces cardiovascular risk, might alter levels of this inflammatory parameter...
Hypertension and borderline isolated systolic hypertension increase risks of cardiovascular disease and mortality in male physiciansC J O'Donnell
Department of Medicine, Brigham and Women s Hospital, Boston, Mass, USA
Circulation 95:1132-7. 1997..The objective of this study was to examine whether definite hypertension and borderline isolated systolic hypertension predict subsequent cardiovascular disease and mortality...
Hormone replacement therapy and increased plasma concentration of C-reactive proteinP M Ridker
Division of Preventive Medicine, Cardiovascular Diseases, Brigham and Women s Hospital, Boston, MA, USA
Circulation 100:713-6. 1999..However, data evaluating this hypothesis are sparse and limited to older women...
Plasma concentration of C-reactive protein and risk of developing peripheral vascular diseaseP M Ridker
Department of Medicine, Brigham and Women s Hospital, Boston, Mass 02115 1204, USA
Circulation 97:425-8. 1998..Whether increased levels of CRP are also associated with the development of symptomatic peripheral arterial disease (PAD) is unknown...
Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) InvestigatorsP M Ridker
Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Mass 02115, USA
Circulation 98:839-44. 1998..We studied whether inflammation after myocardial infarction (MI) is a risk factor for recurrent coronary events and whether randomized treatment with pravastatin reduces that risk...
Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolismP M Ridker
Division of Preventive Medicine, Brigham and Women s Hospital, Boston, MA 02115, USA
Circulation 95:1777-82. 1997....
Hormonal factors and risk of recurrent venous thrombosis: the prevention of recurrent venous thromboembolism trialM Cushman
Department of Medicine, University of Vermont, Burlington, VT 05446, USA
J Thromb Haemost 4:2199-203. 2006..In some but not all studies, men with venous thrombosis had a higher risk of recurrence than women. Information on women with initial hormone-related thrombosis is scant...
Clinical efficacy of an automated high-sensitivity C-reactive protein assayN Rifai
Department of Laboratory Medicine, Children s Hospital, Harvard Medical School, Boston, MA 02115, USA
Clin Chem 45:2136-41. 1999..Prospective studies have shown that C-reactive protein (CRP) can be used to predict risk of future cardiovascular events. High-sensitivity methods for CRP (hs-CRP) measurement are needed for this purpose...
Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial diseaseP M Ridker
Brigham and Women s Hospital, 900 Commonwealth Ave E, Boston, MA 02215, USA
JAMA 285:2481-5. 2001..Several novel risk factors for atherosclerosis have recently been proposed, but few comparative data exist to guide clinical use of these emerging biomarkers...
Prospective evaluation of the angiotensin-converting enzyme insertion/deletion polymorphism and the risk of strokeR Y Zee
Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Boston, Mass 02115, USA
Circulation 99:340-3. 1999..We investigated the association between ACE genotype and the incidence of stroke in a large, prospective, matched case-control sample from the Physicians' Health Study...
Alu-repeat polymorphism in the gene coding for tissue-type plasminogen activator (t-PA) and risks of myocardial infarction among middle-aged menP M Ridker
Division of Preventive Medicine, Brigham and Women s Hospital, Boston, MA 02115, USA
Arterioscler Thromb Vasc Biol 17:1687-90. 1997..In this cohort of middle-aged US men, the presence of the insertion allele of the Alu-repeat polymorphism of the tissue-type plasminogen activator gene is not associated with future risks of myocardial infarction...
A prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in womenG J Blake
Center for Cardiovascular Disease Prevention, Boston, Massachusetts 02215, USA
J Am Coll Cardiol 38:1302-6. 2001..CONCLUSIONS: In contrast to prior data among hyperlipidemic men, the current data suggest that Lp-PLA(2) is not a strong predictor of future cardiovascular risk among unselected women...
Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy menP M Ridker
Division of Cardiovascular Disease, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
Lancet 351:88-92. 1998..Whether concentrations of soluble ICAM-1 (sICAM-1) are raised in apparently healthy individuals who later suffer acute myocardial infarction is unknown...
Influence of genetic variation in the C-reactive protein gene on the inflammatory response during and after acute coronary ischemiaJ Suk Danik
The Donald W Reynolds Center for Cardiovascular Research, Brigham and Women s Hospital, Harvard Medical School, 900 Commonwealth Avenue, Boston, MA 02115, USA
Ann Hum Genet 70:705-16. 2006..Assessment of CRP genetic variants identified patients with higher and lower CRP elevation after acute coronary syndrome...
Qualitative and quantitative effects of APOE genetic variation on plasma C-reactive protein, LDL-cholesterol, and apoE proteinD I Chasman
Division of Preventive Medicine and Center for Cardiovascular Disease Prevention, Brigham and Women s Hospital, Boston, MA 02215, USA
Genes Immun 7:211-9. 2006..Quantitative analysis suggested that the effect on CRP is more likely a consequence of intrinsic functional differences among the E2, E3, and E4 apoE proteins than different levels of apoE protein or LDL-C in the plasma...
High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular diseaseP M Ridker
Center for Cardiovascular Disease Prevention, Divisions of Cardiovascular Diseases and Preventive Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02214, USA
Circulation 103:1813-8. 2001....
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary eventsP M Ridker
Center for Cardiovascular Disease Prevention, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02215, USA
N Engl J Med 344:1959-65. 2001..We hypothesized that statins might prevent coronary events in persons with elevated C-reactive protein levels who did not have overt hyperlipidemia...
Polymorphisms of prostaglandin-endoperoxide synthase 2 gene, and prostaglandin-E receptor 2 gene, C-reactive protein concentrations and risk of atherothrombosis: a nested case-control approachH H Hegener
Center for Cardiovascular Disease Prevention, The Donald W Reynolds Center for Cardiovascular Research, The Leducq Center for Molecular and Genetic Epidemiology, Boston, MA 02215, USA
J Thromb Haemost 4:1718-22. 2006..Recent data have shown an association between polymorphisms of prostaglandin-endoperoxide synthase-2 gene (PTGS2; alias COX-2), and prostaglandin-E receptor-2 gene (PTGER2) and risk of atherothrombotic disorders...
Inflammatory bio-markers and cardiovascular risk predictionG J Blake
Center for Cardiovascular Disease Prevention and the Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 900 Commonwealth Avenue East, Boston, MA 02215, USA
J Intern Med 252:283-94. 2002..Further trials are needed to confirm the potential benefits of statins amongst individuals with elevated CRP levels...
Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US menP M Ridker
Division of Cardiovascular Disease, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Circulation 95:59-62. 1997..In a small group of young Swedish men, this allele has been reported to predict risk of myocardial infarction. Whether this polymorphism increases risk of arterial and venous thrombosis among middle-aged men is unknown...
Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screeningP M Ridker
Division of Preventive Medicine, Brigham and Women s Hospital, Boston, MA 02215 1204, USA
JAMA 277:1305-7. 1997..To estimate ethnic-specific prevalence rates of factor V Leiden, an inherited defect of hemostasis associated with risk of venous thrombosis...
Homocysteine and risk of cardiovascular disease among postmenopausal womenP M Ridker
Division of Cardiovascular Diseases, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass 02115, USA
JAMA 281:1817-21. 1999..Individuals with elevated levels of homocysteine tend to have higher prevalence of cardiovascular disease. However, prospective studies of homocysteine are inconsistent and data among women are limited...
Novel clinical markers of vascular wall inflammationG J Blake
Center for Cardiovascular Disease Prevention, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA
Circ Res 89:763-71. 2001..The addition of CRP screening to traditional lipid testing has the potential to identify individuals at high risk for future cardiovascular events who may benefit from targeted preventive interventions...
Soluble P-selectin and the risk of future cardiovascular eventsP M Ridker
Center for Cardiovascular Disease Prevention, Division of Preventive Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02215, USA
Circulation 103:491-5. 2001..However, little clinical data are available evaluating the role of soluble P-selectin in determining vascular risk...
Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy menP M Ridker
Center for Cardiovascular Disease Prevention and the Divisions of Preventive Medicine, Cardiovascular Diseases, Brigham and Women s Hospital, Boston, MA 02115, USA
Circulation 101:1767-72. 2000..Interleukin-6 (IL-6) plays a central role in inflammation and tissue injury. However, epidemiological data evaluating the role of IL-6 in atherogenesis are sparse...
A prospective evaluation of the interleukin-1 receptor antagonist intron 2 gene polymorphism and the risk of myocardial infarctionR Y Zee
Center for Cardiovascular Disease Prevention, Division of Preventive Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02215 1204, USA
Thromb Haemost 86:1141-3. 2001..These data also highlight the importance of hypothesis testing studies in genetic epidemiology, particularly for hypotheses generated from small samples or post hoc subgroup analyses...
Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy womenP M Ridker
Division of Cardiology, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass, USA
Circulation 98:731-3. 1998..C-reactive protein (CRP) predicts risk of myocardial infarction (MI) and stroke among apparently healthy men, but in women, virtually no data are available...
Renin-angiotensin and endothelial nitric oxide synthase gene polymorphisms are not associated with the risk of incident type 2 diabetes mellitus: a prospective cohort studyD Conen
Division of Preventive Medicine, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02215, USA
J Intern Med 263:376-85. 2008..The aim of this study was to assess the relationship between a set of well-characterized genetic variants of the renin-angiotensin system and the endothelial nitric oxide synthase (NOS3) gene and the incidence of type 2 diabetes...
Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and strokeP M Ridker
Divisions of Preventive Medicine, Cardiovascular Diseases, Department of Medicine, Brigham and Women s Hospital, Boston, Mass 02115, USA
Circulation 98:2796-9. 1998..However, prospective data relating evidence of prior exposure to these agents with risks of future myocardial infarction (MI) and stroke are sparse...
Lipid biomarkers, hormone therapy and the risk of venous thromboembolism in womenB M Everett
The Center for Cardiovascular Disease Prevention, Harvard Medical School, and the Division of Preventive Medicine, Department of Medicine, Brigham and Women s Hospital, Boston, MA 02215, USA
J Thromb Haemost 7:588-96. 2009..Published reports of a relationship between lipids and incident venous thromboembolism (VTE) are conflicting...
Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trialM A Pfeffer
Brigham and Women s Hospital, Boston, Mass, USA
Circulation 95:2643-51. 1997..Although ACE inhibitor therapy has been shown to reduce mortality in patients with acute myocardial infarction (MI), the optimal dose and the timing of its initiation have not been determined...
Association of common CRP gene variants with CRP levels and cardiovascular eventsD T Miller
Division of Hematology, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
Ann Hum Genet 69:623-38. 2005..001). Taken together, these data imply significant interactions between both genetic and environmental contributions to the increased CRP levels that predict a greater risk of future atherothrombotic events in epidemiological studies...
Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort studyM A Albert
Center for Cardiovascular Disease Prevention, Division of Cardiovascular Medicine, Brigham and Women's Hospital, 900 Commonwealth Ave E, Boston, MA 02215, USA
JAMA 286:64-70. 2001..These data provide evidence that statins may have anti-inflammatory effects in addition to lipid-lowering effects...
Lipid levels and the risk of ischemic stroke in womenT Kurth
Brigham and Women s Hospital, Division of Preventive Medicine, Harvard Medical School, Boston, MA 02215, USA
Neurology 68:556-62. 2007....
A prospective evaluation of the CD14 C(-260)T gene polymorphism and the risk of myocardial infarctionR Y Zee
Center of Cardiovascular Disease Prevention, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Atherosclerosis 154:699-702. 2001..Thus, in contrast to prior studies, these data indicate that screening for CD14 C(-260)T genotypes is unlikely to be a useful tool for risk assessment...
Multi-locus candidate gene polymorphisms and risk of myocardial infarction: a population-based, prospective genetic analysisR Y L Zee
Center for Cardiovascular Disease Prevention, Harvard Medical School, Boston, MA 02215, USA
J Thromb Haemost 4:341-8. 2006..Polymorphisms in candidate genes related to lipid metabolism, thrombosis, hemostasis, cell-matrix adhesion, and inflammation have been suggested clinically useful in risk assessment of cardiovascular disease...
HbA1c measured in stored erythrocytes and mortality rate among middle-aged and older womenE B Levitan
Cardiovascular Epidemiology Research Unit, Beth Israel Deaconess Medical Center, 375 Longwood Avenue, MS 443, Boston, MA 02215, USA
Diabetologia 51:267-75. 2008..We examined the association between HbA1c measured in stored erythrocytes and mortality rate in women with and without diabetes...
The pravastatin inflammation CRP evaluation (PRINCE): rationale and designM A Albert
Center for Cardiovascular Disease Prevention, Division of Cardiology and Preventive Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass 02115, USA
Am Heart J 141:893-8. 2001..However, the time course and magnitude of this effect in both primary and secondary prevention is controversial...
Blood pressure and inflammation in apparently healthy menC U Chae
Center for Cardiovascular Disease Prevention, Division of Preventive Medicine, Brigham and Women s Hospital, Boston, MA 02215, USA
Hypertension 38:399-403. 2001..These data suggest that increased blood pressure may be a stimulus for inflammation and that this is a possible mechanism underlying the well-established role of hypertension as a risk factor for atherosclerotic disease...
Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular riskJ A de Lemos
Center for Cardiovascular Disease Prevention, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
J Am Coll Cardiol 36:423-6. 2000..The purpose of this study was to evaluate whether soluble vascular cell adhesion molecule-1 (sVCAM-1) is a marker for increased cardiovascular risk...
Mutation in the promoter region of the beta-fibrinogen gene and the risk of future myocardial infarction, stroke and venous thrombosisG J Blake
The Center for Cardiovascular Disease Prevention, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA
Eur Heart J 22:2262-6. 2001..We investigated whether the distribution of the C148T polymorphism is associated with an increase in cardiovascular risk...
C-reactive protein gene polymorphisms and the risk of venous thromboembolism: a haplotype-based analysisR Y L Zee
Center for Cardiovascular Disease Prevention, Harvard Reynolds Center for Cardiovascular Research, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
J Thromb Haemost 2:1240-3. 2004..66, P = 0.72) yielded similar null findings. In conclusion, we found no evidence for an association between the CRP polymorphisms/haplotypes tested and the risk of venous thromboembolism...
Current issues concerning thrombolytic therapy for acute myocardial infarctionC H Hennekens
Department of Medicine, Brigham and Women s Hospital, Boston, Massachusetts, USA
J Am Coll Cardiol 25:18S-22S. 1995..Whether or not accelerated t-PA has a small advantage for mortality is less conclusive.(ABSTRACT TRUNCATED AT 250 WORDS)..
Migraine and biomarkers of cardiovascular disease in womenT Kurth
Division of Preventive Medicine, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02215 1204, USA
Cephalalgia 28:49-56. 2008..In this large cohort of women, only a modest association was found between migraine and adverse levels of certain cardiovascular biomarkers...
D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolismS Shrivastava
Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Boston, MA, USA
J Thromb Haemost 4:1208-14. 2006..CONCLUSIONS: Among patients with idiopathic VTE, measurement of D-dimer, but not FVIIIc, might be useful for risk stratification. The efficacy of extended low-intensity warfarin therapy did not vary by biomarker level...
Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adultsI S Ockene
Department of Medicine, University of Massachusetts Medical School, 55 Lake Ave North, Worcester, MA 01655, USA
Clin Chem 47:444-50. 2001..Because of its relationship to inflammation, hs-CRP has considerable biologic variation. This study was carried out to characterize CRP variation and to compare it to another risk factor, total serum cholesterol...
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive proteinPaul M Ridker
Center for Cardiovascular Disease Prevention, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02215, USA
N Engl J Med 359:2195-207. 2008....
Evaluating novel cardiovascular risk factors: can we better predict heart attacks?P M Ridker
Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
Ann Intern Med 130:933-7. 1999..Background is also provided to assist physicians in deciding whether one or more of these novel markers deserve clinical consideration in general outpatient settings...
C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarctionP M Ridker
Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass 02215, USA
Circulation 97:2007-11. 1998..However, whether measurement of CRP adds to the predictive value of total cholesterol (TC) and HDL cholesterol (HDL-C) in determining risk is uncertain...
A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African AmericansD Voora
Department of Medicine, Washington University in St Louis, St Louis, Missouri, USA
Clin Pharmacol Ther 87:445-51. 2010..14, one-sided P = 0.03). CALU rs339097 A>G is associated with higher warfarin dose requirements, independent of known genetic and nongenetic predictors of warfarin dose in African Americans...
A prospective study of Helicobacter pylori seropositivity and the risk for future myocardial infarction among socioeconomically similar U.S. menP M Ridker
Center for Cardiovascular Disease Prevention, Brigham and Women s Hospital, 900 Commonwealth Avenue East, Boston, MA 02215, USA
Ann Intern Med 135:184-8. 2001..The role of Helicobacter pylori as a determinant of cardiovascular disease is controversial...
Soluble CD40L and cardiovascular risk in womenU Schonbeck
Leducq Center for Cardiovascular Research, Cardiovascular Medicine, Brigham and Women s Hospital, Boston, Massachusetts, USA
Circulation 104:2266-8. 2001..It is unknown, however, whether elevations of circulating sCD40L precede the onset of acute cardiovascular symptoms...
Inflammation, atherosclerosis, and cardiovascular risk: an epidemiologic viewP M Ridker
Division of Preventive Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Blood Coagul Fibrinolysis 10:S9-12. 1999..Taken together, these data raise the possibility that therapies targeting chronic low-grade inflammation may provide novel future strategies for cardiovascular disease prevention...
Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarctionP M Ridker
Divisions of Cardiology, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
Circulation 99:1161-4. 1999..Chlamydia pneumoniae has been hypothesized to play a role in atherothrombosis. However, prospective data relating exposure to Chlamydia pneumoniae and risks of future myocardial infarction (MI) are sparse...
G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US menP M Ridker
Divisions of Preventive Medicine and Cardiovascular Diseases, Department of Medicine, Brigham and Women s Hospital, Boston, MA, USA
Circulation 99:999-1004. 1999..Whether this mutation increases the risks of arterial and venous thrombosis among healthy individuals is controversial...
Plasma levels of cystatin-C and mannose binding protein are not associated with risk of developing systemic atherosclerosisM A Albert
Center for Cardiovascular Disease Prevention, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Vasc Med 6:145-9. 2001..05). In contrast with prior retrospective and cross-sectional studies, no evidence was found that baseline levels of cystatin-C or mannose binding protein are associated with an increased risk of future arterial disease...
Effect of valsartan compared with valsartan/hydrochlorothiazide on plasma levels of cellular adhesion molecules: the Val-MARC trialD Conen
Center for Cardiovascular Disease Prevention, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02215, USA
Heart 94:e13. 2008....
Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemiaP M Ridker
Center for Cardiovascular Disease Prevention, Brigham and Women s Hospital, Boston, MA 02115, USA
Circulation 103:1191-3. 2001..However, the generalizability, speed of onset, and dose-response characteristics of this effect are uncertain...
High-sensitivity C-reactive protein: a novel and promising marker of coronary heart diseaseN Rifai
Department of Laboratory Medicine, Children s Hospital, Center for Cardiovascular Disease Prevention, Brigham and Women s Hospital, and Harvard Medical School, Boston, MA 02115, USA
Clin Chem 47:403-11. 2001..C-Reactive protein (CRP), an acute phase reactant that reflects low-grade systemic inflammation, has been studied in a variety of cardiovascular diseases...
Vasectomy and subsequent cardiovascular disease in US physiciansJ E Manson
Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
Contraception 59:181-6. 1999..12 (0.94-1.35) for angina/revascularization. These results provide reassuring evidence that vasectomy does not materially increase the risk of subsequent cardiovascular disease, even 15 or more years following the procedure...
Lipid lowering and beyond: results from the CARE study on lipoproteins and inflammation. Cholesterol and Recurrent EventsF M Sacks
Department of Medicine, Harvard Medical School, USA
Herz 24:51-6. 1999..These findings also raise the possibility that the efficacy of pravastatin may partly result from anti-inflammatory as well as lipid lowering properties...
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarinB F Gage
Department of Internal Medicine, Washington University School of Medicine, St Louis, Missouri, USA
Clin Pharmacol Ther 84:326-31. 2008..To facilitate use of these pharmacogenetic and clinical algorithms, we developed a nonprofit website, http://www.WarfarinDosing.org...
Differential leucocyte count and the risk of future coronary artery disease in healthy men and women: the EPIC-Norfolk Prospective Population StudyJ S Rana
Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
J Intern Med 262:678-89. 2007..There is paucity of data on the differential leucocyte count and its relationship with the risk of CHD and CVD...
G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolismJ S Miles
Leducq Center for Molecular and Genetic Epidemiology of Cardiovascular Disorders, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
J Am Coll Cardiol 37:215-8. 2001..The study was done to determine whether the G20210A mutation in the prothrombin gene increases the risk of recurrent venous thromboembolism (VTE), both alone and in combination with factor V Leiden...
A prospective replication study of five gene variants previously associated with risk of myocardial infarctionR Y L Zee
J Thromb Haemost 4:2093-5. 2006
Do atherosclerosis and type 2 diabetes share a common inflammatory basis?A D Pradhan
Eur Heart J 23:831-4. 2002
C-reactive protein and prognosis after percutaneous coronary interventionG J Blake
Eur Heart J 23:923-5. 2002
Carboxypeptidase B2 gene polymorphisms and the risk of venous thromboembolismR Y L Zee
J Thromb Haemost 3:2819-21. 2005
Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarctionL M Hines
Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA
N Engl J Med 344:549-55. 2001..We investigated the relation among the ADH3 polymorphism, the level of alcohol consumption, and the risk of myocardial infarction in a nested case-control study based on data from the prospective Physicians' Health Study...
Cystatin C deficiency in human atherosclerosis and aortic aneurysmsG P Shi
Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
J Clin Invest 104:1191-7. 1999..The findings highlight a potentially important role for imbalance between cysteine proteases and cystatin C in arterial wall remodeling and establish that cystatin C deficiency occurs in vascular disease...
Long-term low-dose warfarin use is effective in the prevention of recurrent venous thromboembolism: yesP M Ridker
Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
J Thromb Haemost 2:1034-7. 2004
Increased inflammatory markers in children with familial hypercholesterolaemiaT Ueland
Research Institute for Internal Medicine, Section of Endocrinology, Rikshospitalet, University of Oslo, Norway
Eur J Clin Invest 36:147-52. 2006....
Tumour necrosis factor-alpha, inflammatory biomarkers, and atherogenesisG J Blake
Eur Heart J 23:345-7. 2002
Inflammatory mechanisms in atherosclerosis: from laboratory evidence to clinical applicationG J Blake
Center for Cardiovascular Disease Prevention, Department of Medicine, Brigham and Women's Hospital, Havard Medical School, Boston, MA 02215, USA
Ital Heart J 2:796-800. 2001..The role of statin therapy for plaque stabilization in acute coronary syndromes, and for prevention of future plaque rupture among healthy individuals with evidence of vascular inflammation, is an area of active research...
